Alternatives to Synthetic Biology Platform

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-guided drug discovery platform for tissue-targeted medicines.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Biotech company focused on designing and developing novel biological solutions.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform accelerating biological research and drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.